4,696 reports of this reaction
3.5% of all BUDESONIDE reports
#4 most reported adverse reaction
ASTHMA is the #4 most commonly reported adverse reaction for BUDESONIDE, manufactured by H2-Pharma LLC. There are 4,696 FDA adverse event reports linking BUDESONIDE to ASTHMA. This represents approximately 3.5% of all 134,730 adverse event reports for this drug.
Patients taking BUDESONIDE who experience asthma should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHMA is moderately reported among BUDESONIDE users, representing a notable but not dominant share of adverse events.
In addition to asthma, the following adverse reactions have been reported for BUDESONIDE:
The following drugs have also been linked to asthma in FDA adverse event reports:
ASTHMA has been reported as an adverse event in 4,696 FDA reports for BUDESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHMA accounts for approximately 3.5% of all adverse event reports for BUDESONIDE, making it a notable side effect.
If you experience asthma while taking BUDESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.